Chemdex raises additional $30M

Chemdex (Palo Alto, CA), a provider of e-commerce solutions for laboratory supply, said it has closed a third round of financing totaling $30 million, consisting of new investors from the venture capital, financial and biomedical industries, as well as previous investors.

The lead investor in the round is Galen Partners, which invests exclusively in mid-to-later-stage IT, in-service, device, and generic drug firms. "Galen’s investment experience and breadth of knowledge in healthcare and science, coupled with Chemdex’s groundbreaking e-commerce technology, creates a powerful partnership with an outstanding future," said L. John Wilkerson, general partner and co-founder of Galen Partners.